| scholarly article | Q13442814 |
| P50 | author | Jeanette Schulz-Menger | Q40942285 |
| P2093 | author name string | Andrew J Taylor | |
| Daniel R Messroghli | |||
| Hassan Abdel-Aty | |||
| Matthias G Friedrich | |||
| Nidal Al-Saadi | |||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | angioplasty | Q539795 |
| microvessel | Q6840468 | ||
| P304 | page(s) | 2080-5 | |
| P577 | publication date | 2004-05-04 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging | |
| P478 | volume | 109 |
| Q37322418 | Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction |
| Q82638981 | Assessment of resting perfusion defects in patients with acute myocardial infarction: comparison of myocardial contrast echocardiography, combined first-pass/delayed contrast-enhanced magnetic resonance imaging and 99mTC-sestamibi SPECT |
| Q40127504 | Association of TIMI myocardial perfusion grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction |
| Q58608459 | Berberine alleviates oxidized low-density lipoprotein-induced macrophage activation by downregulating galectin-3 via the NF-κB and AMPK signaling pathways |
| Q36738090 | Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools |
| Q47191457 | C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction |
| Q36444582 | CMR of microvascular obstruction and hemorrhage in myocardial infarction |
| Q30468452 | Cardiac magnetic resonance imaging in ischemic heart disease: a clinical review. |
| Q40871375 | Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease |
| Q41055137 | Comparison between visual grading and planimetric quantification of microvascular obstruction extent assessment in reperfused acute myocardial infarction |
| Q37278781 | Comparison of wall thickening and ejection fraction by cardiovascular magnetic resonance and echocardiography in acute myocardial infarction |
| Q47261254 | Computer-assisted calculation of myocardial infarct size shortens the evaluation time of contrast-enhanced cardiac MRI. |
| Q36457860 | Contrast agents and cardiac MR imaging of myocardial ischemia: from bench to bedside |
| Q38259726 | Coronary microvascular dysfunction: mechanisms and functional assessment |
| Q37424647 | Detection and characteristics of microvascular obstruction in reperfused acute myocardial infarction using an optimized protocol for contrast-enhanced cardiovascular magnetic resonance imaging |
| Q37376707 | Detection of ischaemic myocardial lesions with coronary CT angiography and adenosine-stress dynamic perfusion imaging using a 128-slice dual-source CT: diagnostic performance in comparison with cardiac MRI |
| Q79955258 | Determinants and impact of microvascular obstruction in successfully reperfused ST-segment elevation myocardial infarction. Assessment by magnetic resonance imaging |
| Q36412765 | Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction |
| Q36063008 | Evaluation of the Clinical and Procedural Predictive Factors of no-Reflow Phenomenon Following Primary Percutaneous Coronary Intervention |
| Q34561959 | Exercise-induced myocardial ischemia detected by cardiopulmonary exercise testing |
| Q82992456 | Head to head comparison of quantitative versus visual analysis of contrast CMR in the setting of myocardial stunning after STEMI: implications on late systolic function and patient outcome |
| Q44641057 | Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers |
| Q47373079 | Impact of microvascular obstruction and infarct size on left ventricular remodeling in reperfused myocardial infarction: a contrast-enhanced cardiac magnetic resonance imaging study. |
| Q47214833 | Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndromes: A meta-analysis of randomized controlled trials |
| Q58570072 | MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI |
| Q38683717 | MRI in the assessment of ischaemic heart disease. |
| Q38605332 | Microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance study |
| Q35772895 | Microvascular perfusion 1 week and 6 months after myocardial infarction by first-pass perfusion cardiovascular magnetic resonance imaging. |
| Q89450886 | Microvascular perfusion in infarcted and remote myocardium after successful primary PCI: angiographic and CMR findings |
| Q30441722 | Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. |
| Q36577567 | No-reflow phenomenon and prognosis in patients with acute myocardial infarction |
| Q58867599 | Perfusion MRI at rest in subacute and chronic myocardial infarct |
| Q26849357 | Post myocardial infarction of the left ventricle: the course ahead seen by cardiac MRI |
| Q50734607 | Predictors of no- reflow during primary angioplasty for acute myocardial infarction, from Medical College Hospital, Trivandrum. |
| Q37945796 | Principles, current status and clinical implications of ischaemic heart disease assessment by cardiac magnetic resonance imaging |
| Q36760564 | Prognosis following acute myocardial infarction: insights from cardiovascular magnetic resonance |
| Q43801285 | Prognostic value of late gadolinium enhancement in cardiovascular magnetic resonance imaging after acute ST-elevation myocardial infarction in comparison with single-photon emission tomography using Tc99m-Sestamibi |
| Q26771326 | Role of cardiovascular magnetic resonance in acute coronary syndrome |
| Q48003421 | Role of first pass and delayed enhancement in assessment of segmental functional recovery after acute myocardial infarction |
| Q88051815 | Role of no reflow and microvascular obstruction in the prognostic stratification of STEMI patients |
| Q51617848 | Serum N-terminal pro-B-type natriuretic peptide levels at the time of hospital admission predict of microvascular obstructions after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. |
| Q50895361 | Severely impaired left ventricular function: tissue characterization by cardiovascular magnetic resonance in a clinical dilemma. |
| Q90242519 | Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update : Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing |
| Q36642702 | Targeting angiogenesis versus myogenesis with cardiac cell therapy |
| Q39304682 | Targeting the dominant mechanism of coronary microvascular dysfunction with intracoronary physiology tests |
| Q35789203 | The Role of Cardiac MRI in Patients with Troponin-Positive Chest Pain and Unobstructed Coronary Arteries. |
| Q37431525 | The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention |
| Q85101610 | The sum of ST-segment elevation is the best predictor of microvascular obstruction in patients treated successfully by primary percutaneous coronary intervention. Cardiovascular magnetic resonance study |
| Q34136121 | Understanding of chest pain in microvascular disease proved by cardiac magnetic resonance image (UMPIRE): study protocol for a randomized controlled trial |
| Q37314823 | Use of cardiovascular magnetic resonance imaging in acute coronary syndromes |
| Q44086659 | Utility of cardiac magnetic resonance imaging, echocardiography and electrocardiography for the prediction of clinical response and long-term survival following cardiac resynchronisation therapy |
| Q80399798 | [Abnormal myocardial perfusion after infarction in patients with persistent TIMI grade-3 flow. Only an acute phenomenon?] |
| Q80577065 | [Cardiac magnetic resonance after an acute myocardial infarction: a rising technique] |
| Q80399781 | [Medium-term changes in myocardial perfusion and ventricular remodeling following acute myocardial infarction] |
Search more.